Development and pharmacological evaluation of liposomes and nanocapsules containing paroxetine hydrochloride
Authors:
- 5 June 2024
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 660, 124304
Abstract
No abstract availableKeywords
Funding Information
- Universidade Feevale
- CNPq (430938/2016-0)
This publication has 82 references indexed in Scilit:
- Vortioxetine liposomes as a novel alternative to improve drug stability under stress conditions: toxicity studies and evaluation of antidepressant-like effectPharmacological Reports, 2022
- Divergent effects of cholesterol on the structure and fluidity of liposome and catanionic vesicle membranesFEBS Letters, 2022
- Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environmentsAdvanced Drug Delivery Reviews, 2019
- General Outline for IR and Raman Spectral Interpretation2018
- Highly sensitive colorimetric immunosensor for influenza virus H5N1 based on enzyme-encapsulated liposomeAnalytica Chimica Acta, 2017
- Paroxetine Hydrochloride2013
- Enhancement of Thermoelectric Figure‐of‐Merit by a Bulk Nanostructuring ApproachAdvanced Functional Materials, 2010
- Nanocapsule formation by interfacial polymer deposition following solvent displacementInternational Journal of Pharmaceutics, 1989
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Acute and chronic stress effects on open field activity in the rat: Implications for a model of depressionNeuroscience & Biobehavioral Reviews, 1981